切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2011, Vol. 05 ›› Issue (06) : 646 -659. doi: 10.3877/cma.j.issn.1674-0807.2011.06.001

专家论坛

Methods of early detection: would clinical breast examination and breast ultrasonography be a good alternative to mammography?
Adrian YS Yip1, WP Chu1, Louis WC Chow1,2,3,(), Wings TY Loo1,3, Eleanor YY Ong1, Wincy Chan3   
  1. 1.Organisation for Oncology and Translational Research, Hong Kong
    2.Clinical Trials Centre, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
    3.Comprehensive Centre for Breast Diseases, UNIMED Medical Institute, Hong Kong
  • 出版日期:2011-12-01
  • 通信作者: Louis WC Chow

Methods of early detection: would clinical breast examination and breast ultrasonography be a good alternative to mammography?

YS Yip Adrian, Chu WP, WC Chow Louis(), TY Loo Wings, YY Ong Eleanor, Chan Wincy   

  • Published:2011-12-01
  • Corresponding author: WC Chow Louis
引用本文:

Adrian YS Yip, WP Chu, Louis WC Chow, Wings TY Loo, Eleanor YY Ong, Wincy Chan. Methods of early detection: would clinical breast examination and breast ultrasonography be a good alternative to mammography?[J/OL]. 中华乳腺病杂志(电子版), 2011, 05(06): 646-659.

YS Yip Adrian, Chu WP, WC Chow Louis, TY Loo Wings, YY Ong Eleanor, Chan Wincy. Methods of early detection: would clinical breast examination and breast ultrasonography be a good alternative to mammography?[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2011, 05(06): 646-659.

Fig 1 First radiological assessment of a 31-year-old patient presented with breast pain.Her mammogram (a, b) was read as excessively dense breasts which decrease the sensitivity of mammogram and her ultrasound (c) was read as hypoechoic lesion highly suggestive of malignancy with infiltrative feature at left breast 3 ∶00. Pathology of the left breast and axilla revealed invasive mucinous carcinoma with metastasis of sentinel and axillary lymph nodes, pT3, G1, N2, M0.
[1]
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002 [J]. CA Cancer J Clin,2005,55(2):74-108.
[2]
Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middleincome countries: overview of the Breast Health Global Initiative Global Summit 2007 [J]. Cancer, 2008, 113(8 Suppl):2221-2243.
[3]
Porter P. “Westernizing” women's risks? Breast cancer in lower-income countries [J]. N Engl J Med,2008,358(3):213-216.
[4]
Pal SK, Mittal B. Improving cancer care in India: prospects and challenges [J]. Asian Pac J Cancer Prev,2004,5(2):226-228.
[5]
Wang Q. Handbook of breast cancer screening and diagnosis [M]. Guangdong: Guangdong Science and Technology Press,2009.
[6]
Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide [M]. Lyon,France: IARC Press,2004.
[7]
Stewart B, Kleihues PE. World cancer report [M]. Lyon, France: IARC Press,2003.
[8]
Jones L, Chilton JA, Hajek RA, et al. Between and within: international perspectives on cancer health disparities [J]. J Clin Oncol,2006,24(14):2204-2208.
[9]
World Health Organisation. Preventing chronic diseases: a vital investment [M]. Geneva, Switzerland: World Health Organisation,2005.
[10]
Yeole BB, Jayant K, Jussawalla DJ. Trends in breast cancer incidence in greater Bombay: an epidemiological assessment[J]. Bull World Health Organ,1990,68(2):245-249.
[11]
Mezzetti M, La Vecchia C, Decarli A, et al. Population attributable risk for breast cancer: diet, nutrition, and physical exercise[J]. J Natl Cancer Inst,1998,90(5):389-394.
[12]
Hortobágyi GN. A time for creative collaboration [J]. Cancer,2008,113(8 Suppl):2217-2220.
[13]
Jemal A, Siegel R, Ward E, et al. Cancer statistics,2006 [J]. CA Cancer J Clin,2006,56(2):106-130.
[14]
Hortobágyi GN, de la Garza Salazar J,Pritchard K, et al. The global breast cancer burden: variations in epidemiology and survival [J]. Clin Breast Cancer,2005,6(5):391-401.
[15]
Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines [J]. Breast J,2006,12(suppl 1): S3-S15.
[16]
Li J, Zhang BN, Fan JH, et al. A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China [J]. BMC Cancer,2011,11:364.
[17]
Chopra R. The Indian scene. J Clin Oncol,2001,19(18 Suppl):106S-111S.
[18]
Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality[J]. Cancer,2003,98(10):2133-2143.
[19]
Hofer TP, Katz SJ. Healthy behaviors among women in the United States and Ontario: the effect on use of preventive care[J]. Am J Public Health,1996,86(12):1755-1759.
[20]
Navarro V. A historical review (1965-1997) of studies on class, health, and quality of life: a personal account [J]. Int J Health Serv,1998,28(3):389-406.
[21]
House JS, Williams DR. ‘Understanding and reducing socioeconomic and racial/ethnic disparities in health', in promoting health: intervention strategies from Social and Behavioral Research [M]. Washington DC, USA: National Academy Press,2000:81-124.
[22]
Dano H, Andersen O, Ewertz M, et al. Socioeconomic status and breast cancer in Denmark [J]. Int J Epidemiol,2003,32(2):218-224.
[23]
Krieger N, Rowley DL, Herman AA, et al. Racism, sexism and social class: implications for studies of health, disease and well-being [J]. Am J Prev Med,1993,9(6 Suppl):82-122.
[24]
Yi JK, Prows SL. Breast cancer screening practices among Cambodian women in Houston, Texas [J]. J Cancer Educ,1996,11(4):221-225.
[25]
Howard DL, Penchansky R., Brown MB. Disaggregating the effects of race on breast cancer survival [J]. Fam Med,1998,30(3):228-235.
[26]
Litaker D, Tomolo A. Association of contextual factors and breast cancer screening: finding new targets to promote early detection [J]. J Womens Health (Larchmt),2007,16(1):36-45.
[27]
Benjamins MR, Kirby JB, Bond Huie SA. County characteristics and racial and ethnic disparities in the use of preventive services [J]. Prev Med,2004,39(4):704-712.
[28]
Burns RB, McCarthy EP, Freund KM, et al. Black women receive less mammography even with similar use of primary care [J]. Ann Intern Med,1996,125(3):173-182.
[29]
McCarthy BD, Yood MU, MacWilliam CH, et al. Screening mammography use: the importance of a population perspective [J]. Am J Prev Med,1996,12(2):91-95.
[30]
Sung JF, Blumenthal DS, Coates RJ, et al. Knowledge, beliefs, attitudes, and cancer screening among inner-city African-American women [J]. J Natl Med Assoc,1997,89(6):405-411.
[31]
Reisch LM, Barton MB, Fletcher SW, et al. Breast cancer screening use by African Americans and Whites in an HMO[J]. J Gen Intern Med,2000,15(4):229-234.
[32]
Lee HY, Ju E, Vang PD, et al. Breast and cervical cancer screening among Asian American women and Latinas: does race/ethnicity matter? [J]. J Womens Health (Larchmt),2010,19(10):1877-1884.
[33]
Guidry JJ, Aday LA, Zhang D, et al. Information sources and barriers to cancer treatment by racial/ethnic minority status of patients [J]. J Cancer Educ,1998,13(1):43-48.
[34]
Stockton D, Davies T, Day N, et al. Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia: earlier diagnosis or better treatment [J]. BMJ,1997,314(7079):472-475. Erratum in: BMJ,1997,314(7082):721.
[35]
Zotov V, Shyyan R, PATH Breast Cancer Assistance Program. Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience [J]. Breast J,2003,9(Suppl 2):S75-S80.
[36]
World Health Organisation. Cancer control: knowledge into action: WHO guide to effective programmes module 3, early detection [M]. Geneva, Switzerland: World Health Organisation,2007.
[37]
Rosenquist CJ, Lindfors KK. Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness [J].Cancer,1998,82(11):2235-2240.
[38]
Moskowitz M. Costs of screening for breast cancer [J]. Radiol Clin North Am,1987,25(5):1031-1037.
[39]
Brown ML Sensitivity analysis in the cost-effectiveness of breast cancer screening [J]. Cancer, 1992, 69(7 Suppl):1963-1967.
[40]
van der Maas PJ, de Koning HJ, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening [J]. Int J Cancer,1989,43(6):1055-1060.
[41]
Harford JB. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all [J]. Lancet Oncol,2011,12(3),306-312.
[42]
Jones LA, Chilton JA, Hajek RA, et al. Between and within: international perspectives on cancer and health disparities[J]. J Clin Oncol,2006,24(14):2204-2208.
[43]
Dinshaw KA, Shastri SS, Patil SS. Cancer Control Programme in India: challenges for the new millennium [J]. Health Adm,2005,17(1):10-13.
[44]
International Atomic Energy Agency. Millions of cancer victims in developing countries lack access to life-saving radiotherapy [C]. Vienna, Austria: IAEA; 2003. http:/ /www. iaea. org/NewsCenter/PressReleases/2003/prn200311.html.Accessed May 19,2010.
[45]
Sambamoorthi U, McAlpine DD. Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women [J]. Prev Med,2003,37(5):475-484.
[46]
Joy JE, Penhoet EE, Petitti DB. Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis(Prepublication) [M]. Washington DC: The National Academies Press,2004.
[47]
Campbell HS, McBean M, Mandin H, et al. Teaching medical students how to perform a clinical breast examination [J].Acad Med,1994,69(12):993-995.
[48]
Hall DC, Adams CK, Stein GH, et al. Improved detection of human breast lesions following experimental training [J].Cancer,1980,46(2):408-414.
[49]
Artmann A, Hellerhoff K, Heywang Köbrunner SH. Screening in women with increased breast cancer risk [J]. Breast Care,2006,1(1):22-25.
[50]
Jatoi I. Screening clinical breast examination [J]. Surg Clin North Am,2003,83(4):789-801.
[51]
Oestreicher N, White E, Lehman CD, et al. Predictors of sensitivity of clinical breast examination (CBE) [J]. Breast Cancer Res Treat,2002,76(1):73-81.
[52]
Saslow D,Hannan J,Osuch J,et al. Clinical breast examination:practical recommendations for optimizing performance and reporting [J]. CA Cancer J Clin,2004,54(6):327-344.
[53]
Auvinen A, Elovainio L, Hakama M. Breast self-examination and survival from breast cancer: a prospective follow-up study [J]. Breast Cancer Res Treat,1996,38(2):161-168.
[54]
Koibuchi Y, Iino Y, Takei H, et al. The effect of mass screening by physical examination combined with regular breast self-examination on clinical stage and course of Japanese women with breast cancer [J]. Oncol Rep,1998,5(1):151-155.
[55]
Interdisciplinary Group for Cancer Care Evaluation (GIVIO). Practice of breast self-examination: disease extent at diagnosis and patterns of surgical care:a report from an Italian study [J]. J Epidemiol Community Health,1991,45(2):112-116.
[56]
Gastrin G, Miller AB, To T, et al. Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland,1973-1986 [J]. Cancer,1994,73(8):2168-2174.
[57]
Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results [J]. J Natl Cancer Ins,2002,94(19):1445-1457.
[58]
Semiglazov VF, Moiseyenko VM, Bavli JL, et al. The role of breast self-examination in early breast cancer detection(results of the 5-years USSR/WHO randomized study in Leningrad) [J]. Eur J Epidemiol,1992,8(4):498-502.
[59]
Kösters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer [J].Cochrane Database Syst Rev,2003, (2): CD003373.
[60]
Weiss NS. Breast cancer mortality in relation to clinical breast examination and breast self-examination [J]. Breast J,2003,9(Suppl 2): S86-S89.
[61]
American Cancer Society. Breast cancer facts and figures 2007-2008 [M]. Atlanta: American Cancer Society, Inc,2008:1-36.
[62]
US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale [J]. Ann Intern Med,2002,137(5 pt 1):344-346.
[63]
Pisano ED, Earp J, Schell M, et al. Screening behavior of women after a false-positive mammogram [J]. Radiology,1998,208(1):245-249.
[64]
Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age [J]. J Natl Cancer Inst,1995,87(10):720-731.
[65]
Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer?The screening clinical breast examination: should it be done? How? [J]. JAMA,1999,282(13):1270-1280.
[66]
Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical breast examination: preliminary results from a Cluster Randomized Controlled Trial in India [J]. J Natl Cancer Inst,2011,103(19):1476-1480.
[67]
Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998 [J]. J Natl Cancer Inst,2000,92(12):971-976.
[68]
Hall FM. Sonography of the breast: controversies and opinions [J]. AJR Am J Roentgenol,1997,169(6):1635-1636.
[69]
Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions [J]. Radiology,1995,196(1):123-134.
[70]
Sickles EA, Filly RA, Callen PW. Breast cancer detection with sonography and mammography: comparison using state-of-the-art equipment [J]. AJR Am J Roentgenol,1983,140(5):843-845.
[71]
Smith DN. Breast ultrasound [J]. Radiol Clin North Am,2001,39(3):485-497.
[72]
Liberman L. Clinical management issues in percutaneous core breast biopsy [J]. Radiol Clin North Am,2000,38(4):791-807.
[73]
Rahbar G, Sie AC, Hansen GC, et al. Benign versus malignant solid breast masses: US differentiation [J]. Radiology,1999,213(3):889-894.
[74]
Gong X, Xu Q, Xu Z, et al. Real-time elastography for the differentiation of benign and malignant breast lesions: a metaanalysis [J]. Breast Cancer Res Treat,2011,130(1):11-18.
[75]
Benson SR, Blue J, Judd K, et al. Ultrasound is now better than mammography for the detection of invasive breast cancer[J]. Am J Surg,2004,188(4):381-385.
[76]
Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer [J]. Radiology,2004,233(3):830-849.
[77]
Crystal P,Strano SD,Shcharynski S,et al. Using sonography to screen women with mammographically dense breasts [J].AJR Am J Roentgenol,2003,181(1):177-182.
[78]
Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients [J]. Radiology,2002,224(2):569-576.
[79]
Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound: a retrospective review [J]. Cancer,1995,76(4):626-630.
[80]
Osako T, Takahashi K, Iwase T, et al. Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 years [J]. Breast Cancer,2007,14(2):229-233.
[81]
Bosch AM, Kessels AG, Beets GL, et al. Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours [J]. Eur J Radiol, 2003,48(3):285-292.
[82]
Fischer U, Kopka L,Grabbe E. Breast carcinoma:effect of preoperative contrast-enhanced MR imaging on the therapeutic approach [J]. Radiology,1999,213(3):881-888.
[83]
Boetes C,Mus RD,Holland R,et al. Breast tumors:comparative accuracy of MR imaging relative to mammography and US for demonstrating extent [J]. Radiology,1995,197(3):743-747.
[84]
黄源, 庞轶, 王琼, 等. 高频超声在亚洲女性中筛查乳腺癌准确性的系统评价[J]. 中华流行病学杂志, 2010,31(11):1296-1299.
[85]
Tsai HW, Twu NF, Ko CC, et al. Compliance with screening mammography and breast sonography of young Asian women[J]. Eur J Obstet Gynecol Reprod Biol,2011,157(1):89-93.
[86]
Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials [J]. Lancet,2002,359(9310):909-919.
[87]
Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening [J]. N Engl J Med,2005,353(17):1773-1783.
[88]
Skaane P, Hofvind S, Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo Ⅱstudy [J]. Radiology, 2007,244(3):708-717.
[89]
Shapiro S, Coleman EA, Broeders M, et al. Breast cancer screening programmes in 22 countries: current policies,administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening [J]. Int J Epidemiol,1998,27(5):735-742.
[90]
van Gils CH, Otten JD, Verbeek AL, et al. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands [J]. J Epidemiol Community Health,1998,52(4):267-271.
[91]
Saarenmaa I, Salminen T, Geiger U, et al. The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography [J]. Breast Cancer Res Treat,2001,67(2):117-123.
[92]
Kerlikowske K, Grady D, Barclay J, et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography [J]. JAMA,1996,276(1):33-38.
[93]
Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers [J]. J Natl Cancer Inst,2000,92(13):1081-1087.
[94]
Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque,New Mexico [J]. Radiology,1998,209(2):511-518.
[95]
Roubidoux MA, Bailey JE, Wray LA, et al. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors [J]. Radiology,2004,230(1):42-48.
[96]
Porter GJ, Evans AJ, Cornford EJ, et al. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival [J]. AJR Am J Roentgenol,2007,188(3):676-683.
[97]
McCormack VA,dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis[J]. Cancer Epidemiol Biomarkers Prev,2006,15(6):1159-1169.
[98]
Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer [J]. N Engl J Med,2007,356(3):227-236.
[99]
Sickles EA. Mammographic detectability of breast microcalcifications [J]. AJR Am J Roentgenol,1982,139(5):913-918.
[100]
Kothari AR, Birch S. Individual and regional determinants of mammography uptake [J]. Can J Public Health, 2004,95(4):290-294.
[101]
Dailey AB, Kasl SV, Holford TR, et al. Neighborhood-level socioeconomic predictors of nonadherence to mammography screening guidelines [J]. Cancer Epidemiol Biomarkers Prev,2007,16(11):2293-2303.
[102]
Zackrisson S, Lindström M, Moghaddassi M, et al. Social predictors of non-attendance in an urban mammographic screening programme: a multilevel analysis [J]. Scand J Public Health,2007,35(5):548-554.
[103]
Boetes C, Stoutjesdijk M. MR imaging in screening women at increased risk for breast cancer [J]. Magn Reson Imaging Clin N Am,2001,9(2):357-372, vii.
[104]
Ford D, Easton DF. The genetics of breast and ovarian cancer [J]. Br J Cancer,1995,72(4):805-812.
[105]
Berrington de Gonzalez A, Berg CD, Visvanathan K, et al. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers[J]. J Natl Cancer Inst,2009,101(3):205-209.
[106]
Mattsson A, Rudén BI, Hall P, et al. Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease [J]. J Natl Cancer Inst,1993,85(20):1679-1685.
[107]
Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study [J]. Radiat Res,1996,145(6):694-707.
[108]
Young KC. Radiation doses in the UK trial of breast screening in women aged 40-48 years [J]. Br J Radiol, 2002,75(892):362-370.
[109]
Armstrong K, Moye E, Williams S, et al. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians [J]. Ann Intern Med,2007,146(7):516-526.
[110]
Allen SA, Cunliffe WJ, Gray J, et al. Pre-operative estimation of primary breast cancer size: a comparison of clinical assessment,mammography and ultrasound [J]. Breast,2001,10(4):299-305.
[111]
Houssami N, Ciatto S, Irwig L, et al. The comparative sensitivity of mammography and ultrasound in women with breast symptoms: an age-specific analysis [J]. Breast,2002,11(2):125-130.
[112]
Potterton AJ, Peakman DJ, Young JR. Ultrasound demonstration of small breast cancers detected by mammographic screening [J]. Clin Radiol,1994,49(11):808-813.
[113]
Pierie JPEN, Perre CI, Levert LM, et al. Clinical assessment, mammography and ultrasonography as methods of measuring the size of breast cancer: a comparison [J]. Breast,1998,7(5):247-250.
[114]
Huang CS, Chang KJ, Chen TH, et al. A population-based cross-over randomized controlled trial of breast cancer screening with alternate mammography and ultrasound for women aged 40 to 49 years in Taiwan [J]. Cancer Res,2009,69(24 Suppl):502S-503S.
[115]
Ohuchi N, Ishida T, Kawai M, et al. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design [J]. Jpn J Clin Oncol,2011,41(2):275-277.
[116]
Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer [J]. JAMA,2008,299(18):2151-2163.
[117]
Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years[J]. Lancet,1990,335(8684):241-246.
[118]
Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial [J]. BMJ,1988,297(6654):943-948.
[119]
Smith RA, Duffy SW, Gabe R, et al. The randomized trials of breast cancer screening: what have we learned? [J].Radiol Clin North Am,2004,42(5):793-806, v.
[120]
Thurfjell EL, Lindgren JA. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years [J]. Radiology,1996,201(2):421-426.
[121]
Hendrick RE, Smith RA,Rutledge JH 3rd,et al. Benefit of screening mammography in women aged 40-49:a new metaanalysis of randomized controlled trials [J]. J Natl Cancer Inst Monogr,1997, (22):87-92.
[122]
Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening [J]. Lancet,2003,361(9367):1405-1410.
[123]
Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data [J]. Cancer Epidemiol Biomarkers Prev,2006,15(1):45-51.
[124]
World Health Organization. WHOSIS Database: Mammography World Markets [M]. New York: Trimark Publications,2005.
[125]
Carlson RW, Anderson BO, Chopra R, et al. Treatment of breast cancer in countries with limited resources[J]. Breast J,2003,9(Suppl 2): S67-S74.
[126]
Brown ML, Goldie SJ, Draisma G, et al. Health service interventions for cancer control in developing countries [M]/ /Jamison DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries. Oxford: Oxford University Press,2006:569-589.
[1] Louis Wing Cheong Chow, Wings Tjing Yung Loo, Qing Liu. Individualized therapy for breast cancer: a decade of improvement[J/OL]. 中华乳腺病杂志(电子版), 2015, 09(04): 223-230.
[2] William Wai Nam Tsang, Wings Tjing Yung Loo, Louis Wing Cheong Chow, Elizabeth Lam Yan Ng, Adrian Yun San Yip, Jianping Chen. Effect of Tai Chi Chuan on serotonin and cortisol for monitoring stress and quality of life in post-treatment breast cancer patients[J/OL]. 中华乳腺病杂志(电子版), 2014, 08(04): 266-272.
[3] TANG Qi, ZHOU Shao-qiang. Giant phyllodes tumor in both breasts: one case report and literature review[J/OL]. 中华乳腺病杂志(电子版), 2013, 07(02): 142-145.
[4] Chong Le, Tian Jin-hui, Gu Jing, Yang Ke-hu. Is it necessary to do axillary dissection in old women with breast cancer? A meta-analysis of randomized clinical trials[J/OL]. 中华乳腺病杂志(电子版), 2012, 06(06): 622-630.
[5] Per E Lønning. Mechanisms of endocrine resistance in breast cancer[J/OL]. 中华乳腺病杂志(电子版), 2012, 06(06): 597-608.
[6] Satoko Suzuki, Miki Mori, Rena Shigenaga, Kenya Suzuki, Katsutoshi Enokido, Terumasa Sawada, Masanori Hirose, Seigo Nakamura. Efficacy of volume navigation in assessment of extent of breast cancer[J/OL]. 中华乳腺病杂志(电子版), 2012, 06(05): 533-538.
[7] Wings T.Y. Loo, Louis W.C. Chow, Adrian Y.S Yip, Mary N.B. Cheung. Application of single and combination therapy of clarithromycin and tamoxifen to suppress breast cancer cell proliferation and metabolism[J/OL]. 中华乳腺病杂志(电子版), 2012, 06(01): 45-53.
[8] Kentaro Tamaki, Hironobu Sasano. New development of breast cancer histological evaluation related to determination of therapeutic option for the patients[J/OL]. 中华乳腺病杂志(电子版), 2011, 05(06): 721-728.
[9] Jun-Xiang Zhang, Da-Qiang Li, Rakesh Kumar. P21-activated kinase 1 and breast cancer[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(05): 544-553.
[10] Kentaro Tamaki, Hironobu Sasano. An analysis of vascularity and neovascularization in surgical pathology materials of breast carcinoma and its clinical significance[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(05): 521-529.
[11] Louis Wing-Cheong Chow, Adrian Yun-San Yip, Eleanor Yuen-Yuen Ong, Chi-Kei Lam, Masakazu Toi. Potential of a COX-2 inhibitor in lowering chemotherapy-induced neutropenia[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(05): 496-507.
[12] Per Eystein Lønning. Role of molecular markers in breast cancer therapy[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(05): 479-495.
阅读次数
全文


摘要